Experts Discuss Role of Cancer Immunotherapy at Bristol-Myers Presentation, Panel Discussion – Immuno-Oncology News
Immuno-Oncology News |
Experts Discuss Role of Cancer Immunotherapy at Bristol-Myers Presentation, Panel Discussion
Immuno-Oncology News Vicki Goodman, MD, head of New Asset Development at BMS, reminds us that immunotherapy can be used early in two settings: as adjuvant therapy to prevent recurrence after surgery, and as neo-adjuvant therapy to shrink the tumor before surgery or … |
